Ovarian Cancer
Often starts in the fallopian tubes and can be hard to detect early. Learn the symptoms, types, and how it’s diagnosed and treated.
Gynecologic Cancers
Gynecologic Cancers
Gynecologic cancers affect the reproductive organs, including the uterus, ovaries, cervix, vagina, and vulva. An estimated 112,000 individuals will be diagnosed with gynecologic cancer in 2026. Understanding the risks, recognizing early symptoms, and getting regular screenings can make a critical difference in treatment and recovery.
Medically Reviewed By: Sarah Adams, MD, OCRA Scientific Advisor
Types of Gynecologic Cancers
Gynecologic cancers are not all the same. Each type begins in a different part of the reproductive system and has distinct signs, risk factors, and treatment approaches. Some, like cervical cancer, may be detected early through regular screening, while others, such as ovarian cancer, are more difficult to diagnose in early stages. Understanding the differences can help guide decisions about prevention, early detection, and care. Explore each cancer type to learn more about symptoms, treatment options, and available support.
Cervical Cancer
Highly preventable through screening and HPV vaccination. Explore symptoms, staging, and how early care can make a difference.
Endometrial Cancer
The most common gynecologic cancer. Learn what symptoms to watch for, who’s at risk, and how it’s treated.
Uterine Sarcoma
A rare cancer of the uterine muscle and support tissues. Find out how it’s different from other uterine cancers and what to expect.
Vaginal Cancer
Vaginal cancer is uncommon, but early detection matters. Learn the signs, risk factors, and next steps for care.
Vulvar Cancer
A cancer affecting the outer genital area. Learn what symptoms to look for, risk factors, and how early treatment can help.
Understanding the Anatomy of Gynecologic Cancers
Ovarian Cancer From Beyond the Ovary
Tune in to this video presentation by Dr. David Huntsman, Professor at the University of British Columbia and the Canada Research Chair in Molecular and Genomic Pathology, for a thought-provoking exploration of what we can learn about ovarian cancer by expanding our knowledge of other gynecologic cancers.
